Description
FLU VACCINE
First action · last action
2012-06-06 · 2012-06-06
Transactions
1
First transaction's obligation
$164,700
Base + all options value (sum of deltas)
$164,700
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
NO SET ASIDE USED.
Offers received
4
SDVOSB flag on record
No
Parent IDV
VA797P12C0021
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2012-06-06+$164,700= $164,700
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2012-06-06 | +$164,700 | $164,700 | FLU VACCINE |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI L4CNEE8TBYW7)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| VA24613J2466 | 246-NETWORK CONTRACTING OFFICE 6 · 6505 · DRUGS AND BIOLOGICALS | $4,490 | FY2013 |
| VA24612P4533 | 246-NETWORK CONTRACTING OFFICE 6 · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $128,760 | FY2012 |
| VA26112F2692 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $79,605 | FY2012 |
| VA26112F2541 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $29,629 | FY2012 |
| VA26112F2239 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $11,528 | FY2012 |
| VA26112F2540 | 261-NETWORK CONTRACT OFFICE 21 · 6505 · DRUGS AND BIOLOGICALS | $20,287 | FY2012 |
Other recipients under 6505 from 580-HOUSTON (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| VA25613F0353 | TALECRIS BIOTHERAPEUTICS HOLDINGS CORP. | 580-HOUSTON | $5,477 | FY2013 |
| VA25613P0134 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $8,806 | FY2013 |
| VA25612P2546 | MCKESSON PLASMA AND BIOLOGICS LLC | 580-HOUSTON | $10,147 | FY2012 |
| VA25612P2560 | BAXTER HEALTHCARE CORPORATION | 580-HOUSTON | $9,088 | FY2012 |
| VA25612F2494 | ACTELION PHARMACEUTICALS US, INC. | 580-HOUSTON | $4,293 | FY2012 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_VA25612F1743_3600_VA797P12C0021_3600 · retrieved 2026-09-26.